Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Hypertriglyceridemia and Cardiovascular Diseases: Revisited.

Han SH, Nicholls SJ, Sakuma I, Zhao D, Koh KK.

Korean Circ J. 2016 Mar;46(2):135-44. doi: 10.4070/kcj.2016.46.2.135. Epub 2016 Mar 21. Review.

2.

The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.

Viecelli AK, Pascoe E, Polkinghorne KR, Hawley C, Paul-Brent PA, Badve SV, Cass A, Heritier S, Kerr PG, Mori TA, Robertson A, Seong HL, Irish AB; FAVOURED study team..

BMC Nephrol. 2015 Jun 27;16:89. doi: 10.1186/s12882-015-0089-2.

3.

Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts.

Würtz P, Havulinna AS, Soininen P, Tynkkynen T, Prieto-Merino D, Tillin T, Ghorbani A, Artati A, Wang Q, Tiainen M, Kangas AJ, Kettunen J, Kaikkonen J, Mikkilä V, Jula A, Kähönen M, Lehtimäki T, Lawlor DA, Gaunt TR, Hughes AD, Sattar N, Illig T, Adamski J, Wang TJ, Perola M, Ripatti S, Vasan RS, Raitakari OT, Gerszten RE, Casas JP, Chaturvedi N, Ala-Korpela M, Salomaa V.

Circulation. 2015 Mar 3;131(9):774-85. doi: 10.1161/CIRCULATIONAHA.114.013116. Epub 2015 Jan 8.

4.

The evidence for α-linolenic acid and cardiovascular disease benefits: Comparisons with eicosapentaenoic acid and docosahexaenoic acid.

Fleming JA, Kris-Etherton PM.

Adv Nutr. 2014 Nov 14;5(6):863S-76S. doi: 10.3945/an.114.005850. Print 2014 Nov. Review.

5.

Baseline plasma fatty acids profile and incident cardiovascular events in the SU.FOL.OM3 trial: the evidence revisited.

Fezeu LK, Laporte F, Kesse-Guyot E, Andreeva VA, Blacher J, Hercberg S, Galan P.

PLoS One. 2014 Apr 7;9(4):e92548. doi: 10.1371/journal.pone.0092548. eCollection 2014.

6.

Effect of essential fatty acids on glucose-induced cytotoxicity to retinal vascular endothelial cells.

Shen J, Shen S, Das UN, Xu G.

Lipids Health Dis. 2012 Jul 10;11:90. doi: 10.1186/1476-511X-11-90.

7.

Docosahexaenoic acid-induced unfolded protein response, cell cycle arrest, and apoptosis in vascular smooth muscle cells are triggered by Ca²⁺-dependent induction of oxidative stress.

Crnkovic S, Riederer M, Lechleitner M, Hallström S, Malli R, Graier WF, Lindenmann J, Popper H, Olschewski H, Olschewski A, Frank S.

Free Radic Biol Med. 2012 May 1;52(9):1786-95. doi: 10.1016/j.freeradbiomed.2012.02.036. Epub 2012 Mar 3.

8.

Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction.

Eussen SR, Geleijnse JM, Giltay EJ, Rompelberg CJ, Klungel OH, Kromhout D.

Eur Heart J. 2012 Jul;33(13):1582-8. doi: 10.1093/eurheartj/ehr499. Epub 2012 Feb 1.

9.

The ω-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation trial--rationale and design.

Mozaffarian D, Marchioli R, Gardner T, Ferrazzi P, O'Gara P, Latini R, Libby P, Lombardi F, Macchia A, Page R, Santini M, Tavazzi L, Tognoni G.

Am Heart J. 2011 Jul;162(1):56-63.e3. doi: 10.1016/j.ahj.2011.03.035. Epub 2011 Jun 12.

10.

Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.

Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S; SU.FOL.OM3 Collaborative Group..

BMJ. 2010 Nov 29;341:c6273. doi: 10.1136/bmj.c6273.

11.

Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia.

Barter P, Ginsberg HN.

Am J Cardiol. 2008 Oct 15;102(8):1040-5. doi: 10.1016/j.amjcard.2008.05.056. Epub 2008 Jul 31. Review. Erratum in: Am J Cardiol. 2009 Feb 1;103(3):435.

Supplemental Content

Loading ...
Support Center